Advisors Asset Management’s Avita Medical RCEL Stock Holding History

Advisors Asset Management’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,130	Closed	-$35K	–	1537
2022 Q1	$35K	Sell	4,130 -19,960	-83%	-$184K	﹤0.01%	1450
2021 Q4	$289K	Sell	24,090 -13,165	-35%	-$201K	﹤0.01%	1143
2021 Q3	$660K	Sell	37,255 -14,223	-28%	-$268K	0.01%	930
2021 Q2	$1.06M	Buy	51,478 +1,014	+2%	+$20K	0.02%	820
2021 Q1	$1M	Buy	50,464 +16,935	+51%	+$394K	0.02%	821
2020 Q4	$623K	Buy	33,529 +15,218	+83%	+$334K	0.01%	906
2020 Q3	$461K	Buy	18,311 +13,555	+285%	+$338K	0.01%	944
2020 Q2	$145K	Buy	+4,756	New	+$145K	﹤0.01%	1238

Other funds holding RCEL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Advisors Asset Management's RCEL Position: Q2 2022 in Review

Advisors Asset Management sold out of Avita Medical (RCEL) in Q2 2022, closing a stake of 4,130 shares — an estimated $35K sold.

Advisors Asset Management first reported a position in RCEL in Q2 2020 and held it in 8 quarters. The position peaked at $1.06M in Q2 2021. 56 funds tracked by Wall St. Rank hold RCEL as of Q2 2022.

Advisors Asset Management reported no remaining Avita Medical position as of Q2 2022 after selling out during the quarter.
Advisors Asset Management sold 4,130 Avita Medical shares in Q2 2022, an estimated $35K.
Advisors Asset Management first reported a position in Avita Medical in Q2 2020 and held it in 8 quarters.
Advisors Asset Management's Avita Medical position peaked at $1.06M in Q2 2021.
56 funds tracked by Wall St. Rank held Avita Medical as of Q2 2022.

Based on Advisors Asset Management's 13F filing for Q2 2022, filed 8 Aug 2022.